2k0t: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: '''Unreleased structure''' The entry 2k0t is ON HOLD until sometime in the future Authors: Bhattacharyya, D., King, C.L., Chaney, S.G., Campbell, S.L. Description: High Resolution Solu...
 
OCA (talk | contribs)
No edit summary
 
(15 intermediate revisions by the same user not shown)
Line 1: Line 1:
'''Unreleased structure'''


The entry 2k0t is ON HOLD until sometime in the future
==High Resolution Solution NMR Structures of Oxaliplatin-DNA Adduct==
<StructureSection load='2k0t' size='340' side='right'caption='[[2k0t]]' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[2k0t]] is a 2 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2K0T OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2K0T FirstGlance]. <br>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR, models</td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=1PT:CYCLOHEXANE-1(R),2(R)-DIAMINE-PLATINUM(II)'>1PT</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2k0t FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2k0t OCA], [https://pdbe.org/2k0t PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2k0t RCSB], [https://www.ebi.ac.uk/pdbsum/2k0t PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2k0t ProSAT]</span></td></tr>
</table>
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
The differences in efficacy and molecular mechanisms of platinum anti-cancer drugs cisplatin (CP) and oxaliplatin (OX) are thought to be partially due to the differences in the DNA conformations of the CP and OX adducts that form on adjacent guanines on DNA, which in turn influence the binding of damage-recognition proteins that control downstream effects of the adducts. Here we report a comprehensive comparison of the structural distortion of DNA caused by CP and OX adducts in the TGGT sequence context using nuclear magnetic resonance (NMR) spectroscopy and molecular dynamics (MD) simulations. When compared to our previous studies in other sequence contexts, these structural studies help us understand the effect of the sequence context on the conformation of Pt-GG DNA adducts. We find that both the sequence context and the type of Pt-GG DNA adduct (CP vs. OX) play an important role in the conformation and the conformational dynamics of Pt-DNA adducts, possibly explaining their influence on the ability of many damage-recognition proteins to bind to Pt-DNA adducts.


Authors: Bhattacharyya, D., King, C.L., Chaney, S.G., Campbell, S.L.
Flanking Bases Influence the Nature of DNA Distortion by Platinum 1,2-Intrastrand (GG) Cross-Links.,Bhattacharyya D, Ramachandran S, Sharma S, Pathmasiri W, King CL, Baskerville-Abraham I, Boysen G, Swenberg JA, Campbell SL, Dokholyan NV, Chaney SG PLoS One. 2011;6(8):e23582. Epub 2011 Aug 10. PMID:21853154<ref>PMID:21853154</ref>


Description: High Resolution Solution NMR Structures of Oxaliplatin-DNA Adduct
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
 
</div>
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jun 11 08:35:16 2008''
<div class="pdbe-citations 2k0t" style="background-color:#fffaf0;"></div>
== References ==
<references/>
__TOC__
</StructureSection>
[[Category: Large Structures]]
[[Category: Bhattacharyya D]]
[[Category: Campbell SL]]
[[Category: Chaney SG]]
[[Category: King CL]]

Latest revision as of 08:16, 13 August 2026

High Resolution Solution NMR Structures of Oxaliplatin-DNA Adduct

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA